wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Skeletal Muscle Relaxants

Total questions: 19

Worksheet time: 10mins

Name
Class
Date
1.

Tizanidine: Mechanism of action?

a)

𝛂2 adrenergic receptor agonist

b)

Dopamine receptor antagonist

c)

Serotonin reuptake inhibitor

d)

Calcium channel blocker

2.

Cisatracurium, atracurium: Which class?

a)

Depolarizing neuromuscular blockers

b)

Non-depolarizing neuromuscular blockers

c)

Muscle relaxants

d)

Local anesthetics

3.

Baclofen: Mechanism of action?

a)

GABA-B receptor agonist

b)

Dopamine receptor antagonist

c)

Serotonin reuptake inhibitor

d)

Norepinephrine reuptake inhibitor

4.

Depolarizing neuromuscular blocking agents: Mechanism of action?

a)

Mimics acetylcholine and acts as agonists at nicotinic receptors on the motor endplate, causing persistent depolarization that leads to initial muscle fasciculations followed by paralysis.

b)

Inhibits acetylcholine release at the neuromuscular junction, preventing muscle contraction.

c)

Blocks nicotinic receptors at the motor endplate, leading to muscle paralysis without depolarization.

d)

Enhances the breakdown of acetylcholine, leading to reduced muscle activation.

5.

  1. Which reaction is responsible for producing laudanosine from certain non-depolarizing muscle relaxants?

a)

Hofmann elimination

b)

Hydrolysis

c)

Transesterification

d)

Decarboxylation

6.

Malignant hyperthermia is a rare but life-threatening adverse reaction to which skeletal muscle relaxant?

a)

Succinylcholine (a depolarizing neuromuscular blocker)

b)

Rocuronium (a non-depolarizing neuromuscular blocker)

c)

Vecuronium (a non-depolarizing neuromuscular blocker)

d)

Atracurium (a non-depolarizing neuromuscular blocker)

7.

What are the two main classifications of neuromuscular blockers?

a)

1. Non-depolarizing neuromuscular blocking agents

b)

2. Depolarizing neuromuscular blocking agents

c)

3. Anticholinergic agents

d)

4. Muscle relaxants

8.

The drug that is used to reverse the effect of non-depolarizing neuromuscular blockers.

a)

Neostigmine

b)

Succinylcholine

c)

Atracurium

d)

Rocuronium

9.

Among baclofen, diazepam, eperisone, tolperisone, and orphenadrine, which drug has the least sedative effect?

a)

Baclofen

b)

Diazepam

c)

Tolperisone

d)

Eperisone

10.

List the antispasmodic drugs used for acute treatment

a)

Cyclobenzaprine

b)

Ibuprofen

c)

Acetaminophen

d)

Tolperisone

11.

Name a depolarizing neuromuscular blocker

a)

Pancuronium

b)

Rocuronium

c)

Succinylcholine

d)

Vecuronium

12.

Non-depolarizing neuromuscular blocking agents: Mechanism of action?

a)

Inhibit the release of acetylcholine from the presynaptic neuron.

b)

Competitively inhibit acetylcholine by binding to nicotinic receptors on the motor endplate, preventing depolarization and muscle contraction.

c)

Enhance the effect of acetylcholine at the neuromuscular junction.

d)

Block the reuptake of acetylcholine in the synaptic cleft.

13.

Dantrolene: Mechanism of action?

a)

Inhibits ryanodine receptors (RyR1) in skeletal muscle, ↓ Ca²⁺ release from the sarcoplasmic reticulum

b)

Stimulates calcium release from the sarcoplasmic reticulum

c)

Inhibits calcium uptake by the sarcoplasmic reticulum

d)

Blocks sodium channels in skeletal muscle

14.

A drug of choice for malignant hyperthermia

a)

Dantrolene

b)

Aspirin

c)

Ibuprofen

d)

Morphine

15.

Spasmolytics used for chronic treatment that act on CNS

a)

Baclofen

b)

Tizanidine

c)

Benzodiazepines (e.g. diazepam, clonazepam)

d)

Carisoprodol

16.

Botulinum toxin A: Mechanism of action?

a)

Inhibits the reuptake of serotonin in the synaptic cleft.

b)

Destroys SNAP-25, inhibiting acetylcholine release at the neuromuscular junction.

c)

Blocks dopamine receptors in the brain.

d)

Enhances the release of norepinephrine at the synapse.

17.

Spasmolytics used for chronic treatment that act on muscle

a)

Dantrolene

b)

Botulinum toxin A

c)

Cyclobenzaprine

d)

Carisoprodol

18.

Benzodiazepines: Mechanism of action?

a)

Inhibition of serotonin reuptake

b)

Positive allosteric modulator of GABA-A receptor

c)

Antagonism of dopamine receptors

d)

Blockade of NMDA receptors

19.

Drug of choice for treating spasticity in patients with multiple sclerosis.

a)

Baclofen

b)

Dantrolene

c)

Tizanidine

d)

Carisoprodol